-
Attention-deficit/hyperactivity disorder subtypes in adolescents with comorbid substance-use disorder.
Tamm L, Adinoff BH, Nakonezny PA, Winhusen TJ, Riggs PD. Attention-deficit/hyperactivity disorder subtypes in adolescents with comorbid substance-use disorder. American Journal of Drug and Alcohol Abuse 2012;38(1):93-100.
-
Randomized multi-site trial of the job seekers’ workshop in patients with substance use disorders.
Svikis DS, Keyser-Marcus L, Stitzer ML, Rieckmann TR, Safford L, Loeb P, Allen T, Luna-Anderson C, Back SE, Cohen J, DeBernardi MA, Dillard B, Forcehimes AA, Jaffee WB, Killeen T, Kolodner KB, Levy MS, Pallas D, Perl HI, Potter JS, Provost SE, Reese K, Sampson R, Sepulveda A, Snead N, Wong CJ, Zweben JE. Randomized multi-site trial of the job seekers' workshop in patients with substance use disorders. Drug and Alcohol Dependence 2012;120(1-3):55-64.
-
Primary outcome indices in illicit drug dependence treatment research: Systematic approach to selection and measurement of drug use end-points in clinical trials.
Donovan DM, Bigelow GE, Brigham GS, Carroll KM, Cohen AJ, Gardin JG, Hamilton JA, Huestis MA, Hughes JR, Lindblad R, Marlatt GA, Preston KL, Selzer JA, Somoza EC, Wakim PG, Wells EA. Primary outcome indices in illicit drug dependence treatment research: Systematic approach to selection and measurement of drug use end-points in clinical trials. Addiction 2012;107(4):694-708.
-
Parent and child agreement on anxiety disorder symptoms using the DISC predictive scales.
Weems CF, Feaster DJ, Horigian VE, Robbins MS. Parent and child agreement on anxiety disorder symptoms using the DISC predictive scales. Assessment 2011;18(2):213-216.
-
Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders [commentary].
McHugo GJ, Fallot RD. Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders [commentary]. Journal of Dual Diagnosis 2011;7(4):280-284.
-
Addiction treatment trials: How gender, race/ethnicity, and age relate to ongoing participation and retention in clinical trials.
Korte JE, Rosa CL, Wakim PG, Perl HI. Addiction treatment trials: How gender, race/ethnicity, and age relate to ongoing participation and retention in clinical trials. Substance Abuse and Rehabilitation 2011;2(1):205-218.
-
Increasing ethnic minority participation in substance abuse clinical trials: Lessons learned in the National Institute on Drug Abuse’s Clinical Trials Network.
Burlew AK, Larios S, Suarez-Morales L, Holmes BW, Venner KL, Chavez R. Increasing ethnic minority participation in substance abuse clinical trials: Lessons learned in the National Institute on Drug Abuse’s Clinical Trials Network. Cultural Diversity and Ethnic Minority Psychology 2011;17(4):345-56.
-
Motivational enhancement therapy for African American substance users: A randomized clinical trial.
Montgomery L, Burlew AK, Kosinski AS, Forcehimes AA. Motivational enhancement therapy for African American substance users: A randomized clinical trial. Cultural Diversity and Ethnic Minority Psychology 2011;17(4):357-365.
-
American Indian methamphetamine and other drug user in the Southwestern United States.
Forcehimes AA, Venner KL, Bogenschutz MP, Foley K, Davis MP, Houck JM, Willie EL, Begaye P. American Indian methamphetamine and other drug user in the Southwestern United States. Cultural Diversity and Ethnic Minority Psychology 2011;17(4):366-76.
-
The substance abuse counseling workforce: Education, preparation, and certification.
Rieckmann TR, Farentinos C, Tillotson CJ, Kocarnik J, McCarty D. The substance abuse counseling workforce: Education, preparation, and certification. Substance Abuse 2011;32(4):180-190.